Nanoparticles and biotemplates with tunable length and methods of manufacturing the same
AssigneePurdue Research Foundation
InventorsKevin Solomon, Kok Zhi Lee, Yu-Hsuan Lee, Michael Harris, Loretta Sue Loesch-Fries
Life of this patent
Estimating the term…
Abstract
Methods and nucleic acid sequences for the synthesis of biotemplates in a non-plant based expression system are provided. Such biotemplates include Barley stripe mosaic virus viral-like particles (BSMV-VLPs) that are capable of self-assembly due to being operatively linked with an origin of self-assembly with the Barley stripe mosaic virus capsid protein (BSMV-CP). Also provided are BSMV-VLPs that are capable of self-assembly due one or more site-directed mutations on the BSMV-CP, and BSMV-VLPs that exhibit enhanced stability due to such site-directed mutation(s).
Claims10
A method of manufacturing a nanoparticle biotemplate comprising the steps of:
- introducing into an isolated host a nucleic acid sequence comprising SEQ ID NO:
- 1 or a functional equivalent thereof that encodes a Barley stripe mosaic virus coat protein (BSMV-CP), and one or both of:
- (a) an origin of self-assembly (OAS) of a Tobacco mosaic virus operatively linked with the BSMV-CP wherein a portion of the nucleic acid sequence that encodes the OAS comprises SEQ ID NO:
- 11 or a functional equivalent thereof, and
- (b) at least one site-directed mutation on the BSMV-CP that facilitates self-assembly of a BSMV viral-like particle by at least replacing a repulsive interaction between at least-two wild-type BSMV-CP subunits with a neutral or attractive interaction between the correlative at least two BSMV-CP subunits of the encoded BSMV-CP,
- wherein the at least one site-directed mutation on the BSMV-CP is:
- at residue E37Q and comprises SEQ ID NO:
- 7,
- at residue E37R and comprises SEQ ID NO:
- 8,
- at residue E62Q and comprises SEQ ID NO:
- 9,
- at residue D68N and comprises SEQ ID NO:
- 2,
- at residue D70N and comprises SEQ ID NO:
- 3,
- at residue D101N and comprises SEQ ID NO:
- 5,
- at residue D101R and comprises SEQ ID NO:
- 6,
- at residue D101K and comprises SEQ ID NO:
- 4, or
- a combination of site mutations comprising two or more of the foregoing;
- expressing the nucleic acid sequence in a microbial expression system to produce self-assembled BSMV viral-like particles (BSMV VLPs);
- and
- isolating the BSMV VLPs from the microbial expression system.
Dependencies are inferred from the claim text.